Prospective randomized clinical trials are essential to confirm these associations and establish causality, Wang said
Throw away any unused medicine after the beyond-use date
doi:10.1038/oby.2011.402 BERICHT ars medici 18 | 2025 633
Competing interests DB received presentation fees (TEVA, Novartis and Pfizer), travel fees (Allergan, TEVA, Pfizer, Abbvie and Lundbeck), advisory board fees (Novartis, Lilly, Teva, Lundbeck, Pfizer and Abbvie) and participated in clinical trials (TEVA, Lundbeck, Novartis, Lilly and Novo Nordisk Foundation) outside of the submitted work
Gastrointestinal side effects remain among the most frequently cited challenges associated with currently marketed GLP-1 therapies and represent a significant driver of discontinuation
Rx semaglutide Wegovy (semaglutide) is a GLP-1 injection for weight loss